Role of NHS in R&D highlighted by ABPI
The ABPI 'warmly welcomed' a recent report by Lord Darzi on the future of the NHS. The body, representing the interests of the UK pharma sector, highlighted in particular Lord Darzi's stated desire to see the UK, "as a world leader in pharmaceutical and medical technology research and development."
While acknowledging the needs of patients to gain access to the best innovative treatments and services, the ABPI observed that discussion on the "value" of treatments often focuses on cost while understating the full health, societal and economic value. "A product is only cost-effective if it is being used," explained Dr Richard Barker, Director General of the ABPI.
"If Lord Darzi's recommendations are to be fulfilled," Barker emphasised that it was, "essential for the UK environment to remain stable and welcoming for innovative industries that have made Britain a global leader in world-class research."
The ABPI drew attention to the report's emphasis on effective change needing to be led locally, driven by clinicians and others working in partnership across the NHS.
Keywords : National Health Service (NHS), Lord Darzi, Review, Report, ABPI, Pharmaceutical Industry, Research and Development
